FDA Lifts Some Abortion Pill Restrictions, Leaves Others in Place: “Ignores the Science and Smacks of Political Interference”

“At a time when abortion care is under attack like never before, especially for folks working to make ends meet, we can’t afford partial solutions.”

—Destiny Lopez, co-president of All* Above All

On Thursday, the U.S. Food and Drug Administration (FDA) lifted a long-standing rule that health care providers must distribute the abortion pill mifepristone to patients in person, but left in place several burdensome restrictions that continue to unnecessarily restrict and stigmatize this safe medication, say advocates. The decision came in response to a case filed by the ACLU on behalf of abortion providers and medical groups.

Read the full article here.

‍